KCNH2 and Familial short QT syndrome: Interestingly, hydroquinidine, aclass I antiarrhythmic drug inhibiting the Nav1.5 channel, could also block Kv11.1, significantly intervene with ventricular tachyarrhythmia induction167 and prolong the QT interval in SQTS patients with Kv11.1 mutations.168